ASCENTAGE PHARMA GROUP INTERNATIONAL (AAPG)
$18.28-$0.45 (-2.42%) Today
Ascentage Pharma Group International is a clinical-stage biotechnology company engaged in the development and sales of novel small-scale therapies for cancers, hepatitis B virus, or HBV, and certain age-related diseases. It focuses on developing therapies that inhibit protein-protein interactions to restore apoptosis or programmed cell death. The Group has one reportable operating segment, which is discovering, developing, and commercializing therapies to address medical needs in hematological malignancies and currently has seven drug candidates in pipeline under research. The company's geographical segments include the United States and Mainland China.
No Form 4 activity for AAPG in the last 90 days.
3 Form 4 filings on record, the earliest from Apr 21, 2026, newest first.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Yifan Zhai - Officer | Option exercise | Ordinary Shares | 92,746 | $0.00 | - | |
| Yifan Zhai - Officer | Option exercise | Ordinary Shares | 95,575 | $0.00 | - | |
| Yifan Zhai - Officer | Grant or award | Restricted stock units | 103,365 | $0.00 | - | |
| Yifan Zhai - Officer | Grant or award | Restricted stock units | 214,999 | $0.00 | - | |
| Yifan Zhai - Officer | Grant or award | Options | 214,988 | $0.00 | - | |
| Yifan Zhai - Officer | Grant or award | Options | 103,364 | $0.00 | - | |
| Yifan Zhai - Officer | Grant or award | Restricted stock units | 92,746 | $0.00 | - | |
| Yifan Zhai - Officer | Option exercise | Restricted stock units | 92,746 | $0.00 | - | |
| Yifan Zhai - Officer | Grant or award | Restricted stock units | 95,575 | $0.00 | - | |
| Yifan Zhai - Officer | Option exercise | Restricted stock units | 95,575 | $0.00 | - | |
| Yifan Zhai - Officer | Grant or award | Restricted stock units | 298,195 | $0.00 | - | |
| Yifan Zhai - Officer | Grant or award | Options | 298,194 | $0.00 | - | |
 Dajun Yang - Officer | Option exercise | Ordinary Shares | 95,575 | $0.00 | - | |
| Dajun Yang - Officer | Option exercise | Ordinary Shares | 92,746 | $0.00 | - | |
| Dajun Yang - Officer | Grant or award | Restricted stock units | 95,575 | $0.00 | - | |
| Dajun Yang - Officer | Option exercise | Restricted stock units | 95,575 | $0.00 | - | |
| Dajun Yang - Officer | Grant or award | Restricted stock units | 298,195 | $0.00 | - | |
| Dajun Yang - Officer | Grant or award | Options | 298,194 | $0.00 | - | |
| Dajun Yang - Officer | Grant or award | Restricted stock units | 103,365 | $0.00 | - | |
| Dajun Yang - Officer | Grant or award | Restricted stock units | 214,999 | $0.00 | - | |
| Dajun Yang - Officer | Grant or award | Options | 214,988 | $0.00 | - | |
| Dajun Yang - Officer | Grant or award | Options | 103,364 | $0.00 | - | |
| Dajun Yang - Officer | Grant or award | Restricted stock units | 92,746 | $0.00 | - | |
| Dajun Yang - Officer | Option exercise | Restricted stock units | 92,746 | $0.00 | - | |
| Veet Misra - Officer | Grant or award | Restricted stock units | 18,584 | $0.00 | - |
ASCENTAGE PHARMA GROUP INTERNATIONAL (AAPG) has filed no insider reports in the last 90 days. The most recent on record is dated 2026-05-22. The full record for AAPG runs to 3 Form 4 filings, the earliest from 2026-04-21. InsiderAlpha tracks every Form 4, Form 144, and 8-K filing in real time.
No insider purchases of AAPG were filed in the last 90 days.
No insider sales of AAPG were filed in the last 90 days.
This page tracks AAPG Form 4 insider transactions, Form 144 sale notices, and 8-K material event disclosures in one timeline. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
Create a free InsiderAlpha account and press Watch on this page to add AAPG to your watchlist. A free account also opens the full scored daily plan with every past day and 3 months of price history. No card is required. Sign up at https://insideralpha.ai/register.
Every Form 4 below links to the original document on SEC EDGAR, so the numbers on this page can be checked against the filing they came from.
Real-time Form 4 alerts, AI-scored daily trade ideas and 10b5-1 plan flags.
